PSAMP
FOLD

P. Schoenfeld Asset Management (PSAM)’s Amicus Therapeutics FOLD Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-363,000
Closed -$5.25M – 39
2026
Q1 		$5.25M Hold
363,000
– – 2.85% 16
2025
Q4 		$5.17M Buy
+363,000
New +$3.57M 1.83% 24

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s FOLD Position: Q2 2026 in Review

P. Schoenfeld Asset Management (PSAM) sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 363,000 shares — an estimated $5.25M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $5.25M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • P. Schoenfeld Asset Management (PSAM) reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • P. Schoenfeld Asset Management (PSAM) sold 363,000 Amicus Therapeutics shares in Q2 2026, an estimated $5.25M.
  • P. Schoenfeld Asset Management (PSAM) first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • P. Schoenfeld Asset Management (PSAM)'s Amicus Therapeutics position peaked at $5.25M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2026, filed 13 Aug 2026.